semaglutide cardiovascular indication FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity semaglutide oral cardiovascular indication 2025

Any drop in haemoglobin and rise in the urea:creatinine ratio is very indicative of an upper GI bleed, as digested haemoglobin produces urea as a by-product and is readily absorbed by the intestine Ensure all patients with melena have a Group and Save performed, with those with any significant haemoglobin drop or haemodynamic instability having blood products cross-matched too

Oral Semaglutide : The oral version (Rybelsus) is less effective in terms of weight loss

Your records should include medical justification, specific formulation modifications, and verification that commercial alternatives cannot meet documented patient needs